Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PATRON: CNI-free immunosuppression with induction, de novo MPA and delayed mTOR inhibition in liver transplant recipients with renal impairment
2007-003561-40Phase 3Completed
- Sponsor
- Regensburg University Medical Center
- Start
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of sirolimus in hepatic disease, chronic kidney disease (CKD) and graft rejection (2 arms), sponsored by Regensburg University Medical Center. Started Feb 2008; status: completed.
02
Drugs
sirolimus
03
Conditions
hepatic diseasechronic kidney disease (CKD)graft rejection
Beyond the preview
Go deeper on 2007-003561-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003561-40.